介绍：Hugo Kubinyi (计算机辅助药物设计)
介绍：Hugo Kubinyi (计算机辅助药物设计)题名[中]: Hugo Kubinyi (计算机辅助药物设计)
题名[英]: Hugo Kubinyi
资源网址: [url]http://www.kubinyi.de/[/url]
简介[英]: Hugo Kubinyi is the 2006 Herman Skolnik Award winner. His lectures on drug design in PDF are free for download.
Hugo Kubinyi was born in Vienna, Austria in 1940 and completed his studies
of Chemistry in Vienna, Austria and at the Max Planck Institute of
Biochemistry, Munich, Germany with a PhD Thesis on the Isolation, Structure
Elucidation and Partial Synthesis of Phorbol Esters. From 1965-1966 he was
at the German Cancer Research Center (DKFZ), Heidelberg, Germany and in 1966
he moved to Knoll AG (now Abbott GmbH & Co. KG), Ludwigshafen, Germany where
he was Research Scientist, Natural Products, Project Manager Chemical
Research, and, from 1972-1984, Department Head of Natural Products Research.
In 1985 he moved to BASF AG, Ludwigshafen, Germany where he was Head of Drug
Design (Molecular Modelling and Protein Crystallography) from 1987-1998, and
Head of Combinatorial Chemistry and Molecular Modelling (including Protein
Crystallography and Drug Design) from 1998-2001. From 1986 he was also
Professor of Pharmaceutical Chemistry at the University of Heidelberg,
Germany.
In his career, he has received many awards and has published five books on
QSAR, 3D QSAR, and Drug Design. He is also Editor of the
Wiley-VCH book series Methods and Principles in
Medicinal Chemistry together with Prof. Raimund Mannhold, University of
D黶seldorf, Germany, and Prof. Gerd Folkers, ETH Zurich, Switzerland. He was
Vice-Chair (1991) and Chair (1993) of the Gordon Research Conference
"Quantitative Structure-Activity Relationships", 1995-2000 Chair of
The QSAR and Modelling Society (Deputy Chair
2001-2005) and member of the Editorial Boards of the journals Current Drug
Discovery, Current Opinion in Drug Discovery & Development, Journal of
Chemical Information and Computer Sciences, Medicinal Chemistry Research,
and Quantitative Structure-Activity Relationships, Highlight Advisor of
Nature Reviews in Drug Discovery (see also Nature's
Drug Discovery Portal) and a Member of the
Scientific Advisory Boards of several software and start-up companies.
页:
[1]
